Cargando…
Identification of a Novel Homozygous Splice-Site Mutation in SCARB2 that Causes Progressive Myoclonus Epilepsy with or without Renal Failure
BACKGROUND: Progressive myoclonus epilepsies (PMEs) comprise a group of rare genetic disorders characterized by action myoclonus, epileptic seizures, and ataxia with progressive neurologic decline. Due to clinical and genetic heterogeneity of PMEs, it is difficult to decide which genes are affected....
Autores principales: | He, Jin, Lin, Han, Li, Jin-Jing, Su, Hui-Zhen, Wang, Dan-Ni, Lin, Yu, Wang, Ning, Chen, Wan-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032684/ https://www.ncbi.nlm.nih.gov/pubmed/29941711 http://dx.doi.org/10.4103/0366-6999.235113 |
Ejemplares similares
-
Miglustat Therapy for SCARB2-Associated Action Myoclonus–Renal Failure Syndrome
por: Quraishi, Imran H., et al.
Publicado: (2021) -
Novel SCARB2 mutation in action myoclonus-renal failure syndrome and evaluation of SCARB2 mutations in isolated AMRF features
por: Hopfner, Franziska, et al.
Publicado: (2011) -
Case Report: Distinctive EEG Patterns in SCARB-2 Related Progressive Myoclonus Epilepsy
por: Hotait, Mostafa, et al.
Publicado: (2020) -
Late-onset Juvenile Myoclonic Epilepsy or Frontal Lobe Epilepsy with Myoclonus
por: Zhang, Xin-Yue, et al.
Publicado: (2016) -
Perampanel improved intractable myoclonus in two patients with myoclonus epilepsy
por: Iijima, Mutsumi, et al.
Publicado: (2019)